Clinical Models for Integrative Internal Medicine

The Model Is Not a Fixed Template

The most important contribution of this type of article is not to prescribe a uniform treatment for every disease, but rather to elucidate the clinical workflow of integrating traditional Chinese and Western medicine. First, one must determine the nature of the disease; then, assess the predominant syndrome pattern; and finally decide what roles should be assigned to traditional Chinese medicine and Western medicine, respectively.

Disease and Syndrome Coexist

The author emphasizes that “disease” helps us understand the organs, pathology, and stages involved, while “syndrome” enables us to grasp the overall response, constitutional factors, and trends of change. Using both together means that clinical practice has both clear boundaries and flexibility.

Impact on the Partner Medicinal Formula Asset Page

Materials such as the “Lanzhou Formula” should not be understood in isolation as a single formula entry; instead, they should be viewed within the clinical model described in this chapter. In other words, the asset entries themselves are not isolated—they serve an integrated therapeutic logic as a whole.

Implications for Collaborative Communication

If future communication is directed toward pharmaceutical companies or research teams, simply presenting the formula name and its indications will not suffice. It is also necessary to explain which theoretical model it is based on, what stage of research it is in, and what types of development issues it is best suited to address.